Christian S. Schade
2018
In 2018, Christian S. Schade earned a total compensation of $593.3K as President and Chief Executive Officer at Aprea Therapeutics.
Compensation breakdown
| Bonus | $181,280 |
|---|---|
| Salary | $412,000 |
| Total | $593,280 |
Schade received $412K in salary, accounting for 69% of the total pay in 2018.
Schade also received $181.3K in bonus.
Rankings
In 2018, Christian S. Schade's compensation ranked 11,324th out of 14,244 executives tracked by ExecPay. In other words, Schade earned more than 20.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,324 out of 14,244 | 21st |
Division Manufacturing | 4,581 out of 5,765 | 21st |
Major group Chemicals And Allied Products | 1,739 out of 2,128 | 18th |
Industry group Drugs | 1,478 out of 1,817 | 19th |
Industry Pharmaceutical Preparations | 1,134 out of 1,391 | 19th |
Source: SEC filing on April 29, 2020.
News
Aprea Therapeutics CEO Christian Schade's 2022 pay falls 58% to $1.4M
July 11, 2023
Aprea Therapeutics CEO Christian Schade's 2021 pay slips 17% to $3.2M
June 10, 2022
Aprea Therapeutics CEO Christian Schade's 2020 pay rises 6% to $3.9M
April 28, 2021
Aprea Therapeutics CEO Christian Schade's 2019 pay jumps 520% to $3.7M
April 29, 2020